The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Platinum‐based chemotherapy is recommended for the treatment of advanced gastroenteropancreatic neuroendocrine carcinoma (GEP‐NEC). The objective of the current phase 2 study was to compare the efficacy and toxicity between etoposide and cisplatin (EP) and irinotecan and cisplatin (IP) as first‐line treatment in patients with advanced GEP‐NEC.
Methods
Patients with advanced, poorly differentiated...
Objective To evaluate the efficacy and safety of cetuximab combined with chemotherapy in colorectal cancer (CRC). Methods 35 cases of CRC were retrospectively analyzed. Efficacy and adverse events were observed. Results 29 cases of CRC were evaluated by RECIST criteria, showing 7 PR (partial response, 24.1%) and 15 SD (stable disease, 51.8%), disease control rate (DC) was 75.9%. Subgroup analysis...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.